SHMT1 and neoplasm: Furthermore, silencing SHMT1 with low SLC19A1 expression inhibits tumor growth by impairing pyrimidine biosynthesis in vitro and in vivo, whereas silencing SHMT1 with SLC19A1 overexpression cannot alleviate tumor growth.